Prudential PLC lowered its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 5.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,747 shares of the company's stock after selling 5,658 shares during the period. Prudential PLC's holdings in Colgate-Palmolive were worth $8,795,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth about $26,000. Centricity Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc bought a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $33,000. Institutional investors own 80.41% of the company's stock.
Colgate-Palmolive Stock Performance
CL traded up $0.79 during midday trading on Thursday, hitting $91.02. 2,281,537 shares of the company traded hands, compared to its average volume of 4,565,788. The company's 50-day moving average is $90.24 and its 200 day moving average is $92.80. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $73.83 billion, a PE ratio of 25.87, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive declared that its board has authorized a stock buyback program on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's management believes its shares are undervalued.
Colgate-Palmolive Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a $0.52 dividend. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 59.09%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on CL shares. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Friday, April 4th. Morgan Stanley lowered their target price on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Raymond James restated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Stifel Nicolaus dropped their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. Finally, Barclays upped their price objective on shares of Colgate-Palmolive from $83.00 to $89.00 and gave the stock an "equal weight" rating in a report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and a consensus price target of $102.06.
Check Out Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
